APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: These results suggest that a co-injection of both apoA-I and CIGB-258 was more effective in preventing cellular apoptosis, even though injection of either apoA-I or CIGB-258 was also effective in preventing apoptosis in the presence of CML.